| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/30/2008 | CN101167953A Traditional Chinese-medicinal capsule for comprehensive treating diabetes and its producing process |
| 04/30/2008 | CN101167929A Method for producing high-density lipoprotein biological regulator |
| 04/30/2008 | CN101167922A Traditional Chinese medicine preparation |
| 04/30/2008 | CN101167906A Medicinal composition for reducing blood lipid and reducing weight and preparation process thereof |
| 04/30/2008 | CN101167904A Medicinal composition for treating hyperlipemia and its preparing process |
| 04/30/2008 | CN101167899A Medicine for treating diabetes and its preparation method |
| 04/30/2008 | CN101167888A Traditional Chinese medicine preparation for reducing blood pressure and regulating blood lipid |
| 04/30/2008 | CN101167887A Orally-administered matrimony vine single preparation traditional Chinese medicine for treating diabetes and preparation method thereof |
| 04/30/2008 | CN101167875A Traditional Chinese medicinal preparation for treating diabetes and its preparing process |
| 04/30/2008 | CN101167863A Proprietary Chinese medicine for treating diabetes and nephrosis and preparing method thereof |
| 04/30/2008 | CN101167862A Traditional Chinese medicine compound preparation for treating diabetes and nephrosis and preparing method thereof |
| 04/30/2008 | CN101167861A Hypoglycemic compound traditional Chinese medicine liquid preparation and preparation method thereof |
| 04/30/2008 | CN101167846A Capsule with blood sugar reducing function and preparation method thereof |
| 04/30/2008 | CN101167832A Blood lipid reducing stone-eliminating oral liquid and its preparing method |
| 04/30/2008 | CN101167810A Externally treating internal illness plaster for treating diabetes and preparation method |
| 04/30/2008 | CN101167802A Method for preparing cinnamon extraction, cinnamon extraction and its composition and use |
| 04/30/2008 | CN101167796A Monascus and red sage root composition for preventing and treating cardiovascular and cerebrovascular diseases |
| 04/30/2008 | CN101167793A Walnut oil fat emulsion and manufacturing method thereof |
| 04/30/2008 | CN101167784A Medicinal composition for cardiovascular and cerebrovascular diseases |
| 04/30/2008 | CN101167781A Orally-administered hypoglycemic sweet potato leaf single prescription traditional Chinese medicine and preparation method thereof |
| 04/30/2008 | CN101167776A Chicory seed effective part and preparation method and application thereof |
| 04/30/2008 | CN101167775A Method for extracting chrysanthemum total flavone |
| 04/30/2008 | CN101167763A Monascus and total ginkgolide composition for preventing and treating cardiovascular and cerebrovascular diseases |
| 04/30/2008 | CN101167757A New use of bee and/or borer development production for treating diabetes |
| 04/30/2008 | CN101167753A Application of sea collagen peptide as preparation of hypoglycemic medicine, health-care food or food |
| 04/30/2008 | CN101167743A Compound xylitol electrolyte injection and preparation method thereof |
| 04/30/2008 | CN101167740A Compound sodium acetate electrolyte injection and preparation method thereof |
| 04/30/2008 | CN101167739A Compound fructose electrolyte injection and preparation method thereof |
| 04/30/2008 | CN101167731A Dispersible tablet containing metformin and glibenclamide and preparation method thereof |
| 04/30/2008 | CN101167726A Rosiglitazone maleate dispersible tablet and preparation method thereof |
| 04/30/2008 | CN101167721A Compound preparation containing orlistat |
| 04/30/2008 | CN101167699A Insulin sustained-release oral preparation and preparation method thereof |
| 04/30/2008 | CN101167575A Tea polysaccharide lozenge |
| 04/30/2008 | CN101167526A Health product for dog and cat with growth promoting function |
| 04/30/2008 | CN101167525A Health product for dog and cat with hair-beautifying and genital function regulating action |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384852C Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase |
| 04/30/2008 | CN100384844C Xanthine phosphodiesterase V inhibitor polymorphs |
| 04/30/2008 | CN100384841C Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 04/30/2008 | CN100384830C Derivative of cyclo membranousol kind and application thereof |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/30/2008 | CN100384485C Microbiological cellulose injury dressing for treating chronic injury |
| 04/30/2008 | CN100384477C Complex of modafinil and cyclodextrin |
| 04/30/2008 | CN100384460C Chinese proprietary medicine for regulating blood sugar and application thereof |
| 04/30/2008 | CN100384442C Chinese herbal medicine preparation and its preparing process and application |
| 04/30/2008 | CN100384437C Botanical medicine for preventing and treating arteriosclerosis and regulating blood fat and its processing method |
| 04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 04/30/2008 | CN100384429C Capsule for treating cardiac and cerebral vascular diseases and its preparing method and application |
| 04/30/2008 | CN100384412C Methods and compositions for inhibiting 5 'alpha'-reductase activity |
| 04/29/2008 | US7365225 Aryl dicarboxamides |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365084 Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365079 2-(2-naphthyl)-4'-[3-oxospiro[6-azaisobenzofuran-1(3H),1-cyclohexan]-4'-yl]-1H-imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7364764 Soluble roasted chicory having high inulin content |
| 04/29/2008 | US7364751 By adding an antioxidant and/or a chelating agent in the same aqueous solution; reduced coenzyme Q10, vitamin C and ethylenediaminetetracetic acid for example |
| 04/29/2008 | CA2416492C Treatment of glycogen storage disease type ii |
| 04/29/2008 | CA2406798C Pharmaceutical parenteral composition containing a biphosphonate |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/29/2008 | CA2337667C Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2312990C Novel salts of metformin and method |
| 04/29/2008 | CA2297756C Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
| 04/29/2008 | CA2266416C Insulin c-peptides |
| 04/29/2008 | CA2250485C Diagnostic agent for diabetes |
| 04/24/2008 | WO2008049121A2 Hydroxycitric acid compositions, methods of making, and therapeutic uses of same |
| 04/24/2008 | WO2008048770A1 Methods, compositions, and formulations for the treatment of thyroid eye disease |
| 04/24/2008 | WO2008048503A2 Imidazole substitured pyrazole kinase inhibitors |
| 04/24/2008 | WO2008048084A1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure |
| 04/24/2008 | WO2008048057A1 Myonectin and uses thereof |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047769A1 Glucose metabolism ameliorating agent |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047544A1 Diaryl ketimine derivative |
| 04/24/2008 | WO2008046857A1 Long-term enteral feed for maintenance |
| 04/24/2008 | WO2008046521A1 Preparation for oral administration (ii) |
| 04/24/2008 | WO2008046497A1 3 -amino-imidazo [1,2 -a] pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes |
| 04/24/2008 | WO2008046226A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/24/2008 | WO2008046155A1 Methods for regulating glucose homeostasis and agents therefor |
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | WO2008014299A3 Use of an alpha2-agonist composition for the treatment of hyperlipidemia |
| 04/24/2008 | WO2008006224A8 Medicagenic acid saponin and uses thereof |
| 04/24/2008 | WO2007091151A3 A synergistic pharmaceutical and/or neutraceutical flavanoid composition for management of diabetes mellitus |
| 04/24/2008 | WO2007032028A8 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 04/24/2008 | WO2007030721A9 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096962 tert-Butyl 2-{2-[1-ethyl-3-(4-trifluoromethoxy-phenyl)-ureido]-indan-5-ylsulfanyl}-2-methyl-propionate; peroximose proliferator activated receptor antagonist; cardiovascular desease, diabetes; coupling N(5mercapto-indan-2yl)acetamide with (2methyl-2halo) propionate and 2-(4-hydroxyphenoxy)propionic acid |
| 04/24/2008 | US20080096954 Novel Bicyclic Compounds As Modulators of Androgen Receptor Function And Method |
| 04/24/2008 | US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096937 For example, 2-{4-[(2-chloro-benzyl)-ethyl-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |